Qiagen NV | QIA - Market Capitalization


Qiagen NV reported $8.51B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
argenx SE USD 57.63B 13.25B Jun/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
IQVIA Holdings USD 32.25B 3.62B Jun/2026
Organon & Co USD 3.56B 1.99B Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Viatris USD 18.49B 2.76B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026